HEADER ISOMERASE 27-NOV-23 8R7U TITLE CRYSTAL STRUCTURE OF CYCLOPHILIN TGCYP23 FROM TOXOPLASMA GONDII IN TITLE 2 COMPLEX WITH DIHYDRO CYCLOSPORIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: PPIASE; COMPND 5 EC: 5.2.1.8; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: THERE ARE TWO ADDITIONAL RESIDUES IN N-TERM, THAT COMPND 8 REMAIN AFTER THE HIS TAG CLEAVAGE AND ARE NOT OBSERVED IN DENSITY. COMPND 9 GLYCINE (-1) HISTIDINE (0); COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: DIHYDROCYCLOSPORIN A; COMPND 12 CHAIN: C, D; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TOXOPLASMA GONDII; SOURCE 3 ORGANISM_TAXID: 5811; SOURCE 4 GENE: TGRH88_026260; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 10 ORGANISM_TAXID: 32630 KEYWDS CYCLOPHILIN COMPLEX, PEPTIDYLPROLYL ISOMERASE ACTIVITY, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR E.JIMENEZ-FARACO,J.A.HERMOSO REVDAT 1 30-OCT-24 8R7U 0 JRNL AUTH F.FAVRETTO,E.JIMENEZ-FARACO,G.CATUCCI,A.DI MATTEO, JRNL AUTH 2 C.TRAVAGLINI-ALLOCATELLI,S.J.SADEGHI,P.DOMINICI,J.A.HERMOSO, JRNL AUTH 3 A.ASTEGNO JRNL TITL EVALUATING THE POTENTIAL OF NON-IMMUNOSUPPRESSIVE JRNL TITL 2 CYCLOSPORIN ANALOGS FOR TARGETING TOXOPLASMA GONDII JRNL TITL 3 CYCLOPHILIN: INSIGHTS FROM STRUCTURAL STUDIES. JRNL REF PROTEIN SCI. V. 33 E5157 2024 JRNL REFN ESSN 1469-896X JRNL PMID 39312281 JRNL DOI 10.1002/PRO.5157 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.JIMENEZ-FARACO,J.A.HERMOSO REMARK 1 TITL STRUCTURAL BASIS FOR CYCLOSPORIN ISOFORM-SPECIFIC INHIBITION REMARK 1 TITL 2 OF CYCLOPHILINS FROM TOXOPLASMA GONDII IN COMPLEX WITH REMARK 1 TITL 3 CYCLOSPORIN A AT 1.1 ANGSTROMS RESOLUTION REMARK 1 REF ACS INFECT DIS V. 9 365 2023 REMARK 1 REFN ESSN 2373-8227 REMARK 1 PMID 36653744 REMARK 1 DOI 10.1107/S2052252514009324 REMARK 2 REMARK 2 RESOLUTION. 1.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0405 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 125841 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.187 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 6379 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3942 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.86 REMARK 3 BIN R VALUE (WORKING SET) : 0.3727 REMARK 3 BIN FREE R VALUE SET COUNT : 192 REMARK 3 BIN FREE R VALUE : 0.3719 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3250 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 448 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.96 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.07 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.150 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 13 B 301 REMARK 3 ORIGIN FOR THE GROUP (A): 9.0928 -20.8619 16.3629 REMARK 3 T TENSOR REMARK 3 T11: 0.0906 T22: 0.1145 REMARK 3 T33: 0.1221 T12: 0.0248 REMARK 3 T13: -0.0200 T23: -0.0365 REMARK 3 L TENSOR REMARK 3 L11: 0.9717 L22: 2.1319 REMARK 3 L33: 1.1996 L12: -0.1884 REMARK 3 L13: 0.4576 L23: 0.1584 REMARK 3 S TENSOR REMARK 3 S11: -0.0620 S12: -0.1262 S13: 0.0012 REMARK 3 S21: 0.1914 S22: 0.1007 S23: -0.1507 REMARK 3 S31: 0.0026 S32: -0.0734 S33: -0.0272 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 13 A 301 REMARK 3 ORIGIN FOR THE GROUP (A): 0.0164 -55.6528 7.7744 REMARK 3 T TENSOR REMARK 3 T11: 0.1223 T22: 0.1233 REMARK 3 T33: 0.1153 T12: -0.0329 REMARK 3 T13: -0.0209 T23: 0.0403 REMARK 3 L TENSOR REMARK 3 L11: 1.5798 L22: 3.8065 REMARK 3 L33: 0.7865 L12: 1.4059 REMARK 3 L13: 0.2226 L23: 0.4583 REMARK 3 S TENSOR REMARK 3 S11: 0.1470 S12: -0.2025 S13: -0.0267 REMARK 3 S21: 0.2246 S22: -0.2365 S23: -0.1078 REMARK 3 S31: -0.0062 S32: 0.0092 S33: 0.0802 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.10 REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8R7U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-DEC-23. REMARK 100 THE DEPOSITION ID IS D_1292134878. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-SEP-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979260 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS 0.86 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.13 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 125896 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.200 REMARK 200 RESOLUTION RANGE LOW (A) : 42.960 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 1.02800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.450 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CITRIC ACID PH 3.5, AND 25% REMARK 280 POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 59.05450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. HERE, CYCLOSPORIN A IS REMARK 400 REPRESENTED BY THE SEQUENCE (SEQRES) DIHYDROCYCLOSPORIN A, IS A REMARK 400 DERIVATIVE OF CYCLOSPORIN A THAT IS NOT IMMUNOSUPPRESSIVE. IT HAS REMARK 400 BEEN SHOWN TO INHIBIT GROWTH OF LEISHMANIA DONOVANI. REMARK 400 REMARK 400 THE DIHYDROCYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: DIHYDROCYCLOSPORIN A REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: Analogue of cyclosporine A. It is a cyclic REMARK 400 undecapeptide. Cyclization is achieved by linking REMARK 400 the N- and the C- termini. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 PRO B 3 REMARK 465 ALA B 4 REMARK 465 PRO B 5 REMARK 465 PRO B 6 REMARK 465 ALA B 7 REMARK 465 ASN B 8 REMARK 465 SER B 9 REMARK 465 GLY B 10 REMARK 465 GLU B 11 REMARK 465 SER B 12 REMARK 465 GLY A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 PRO A 3 REMARK 465 ALA A 4 REMARK 465 PRO A 5 REMARK 465 PRO A 6 REMARK 465 ALA A 7 REMARK 465 ASN A 8 REMARK 465 SER A 9 REMARK 465 GLY A 10 REMARK 465 GLU A 11 REMARK 465 SER A 12 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 DAL C 1 C MLE C 2 N 0.152 REMARK 500 MLE C 2 C MLE C 3 N 0.146 REMARK 500 MLE C 3 C MVA C 4 N 0.148 REMARK 500 MVA C 4 C TMD C 5 N 0.175 REMARK 500 TMD C 5 C ABA C 6 N 0.187 REMARK 500 ABA C 6 C SAR C 7 N 0.201 REMARK 500 SAR C 7 C MLE C 8 N 0.199 REMARK 500 MLE C 8 C VAL C 9 N 0.186 REMARK 500 VAL C 9 C MLE C 10 N 0.167 REMARK 500 MLE C 10 C ALA C 11 N 0.152 REMARK 500 DAL D 1 C MLE D 2 N 0.186 REMARK 500 MLE D 2 C MLE D 3 N 0.194 REMARK 500 MLE D 3 C MVA D 4 N 0.184 REMARK 500 MVA D 4 C TMD D 5 N 0.188 REMARK 500 TMD D 5 C ABA D 6 N 0.191 REMARK 500 ABA D 6 C SAR D 7 N 0.191 REMARK 500 SAR D 7 C MLE D 8 N 0.188 REMARK 500 MLE D 8 C VAL D 9 N 0.199 REMARK 500 VAL D 9 C MLE D 10 N 0.197 REMARK 500 MLE D 10 C ALA D 11 N 0.171 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE B 104 -77.17 -129.00 REMARK 500 CYS B 163 59.96 -152.04 REMARK 500 PHE A 104 -75.72 -130.56 REMARK 500 CYS A 163 60.75 -153.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG B 168 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 522 DISTANCE = 6.18 ANGSTROMS REMARK 525 HOH B 523 DISTANCE = 6.47 ANGSTROMS REMARK 525 HOH A 506 DISTANCE = 5.82 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8R7T RELATED DB: PDB REMARK 900 8R7S CONTAINS THE SAME PROTEIN WITH ALISPORIVIR REMARK 900 RELATED ID: 8R7S RELATED DB: PDB REMARK 900 8R7S CONTAINS THE SAME PROTEIN WITH NIM811 DBREF1 8R7U B 1 211 UNP A0A7J6KAD1_TOXGO DBREF2 8R7U B A0A7J6KAD1 1 211 DBREF1 8R7U A 1 211 UNP A0A7J6KAD1_TOXGO DBREF2 8R7U A A0A7J6KAD1 1 211 DBREF 8R7U C 1 11 PDB 8R7U 8R7U 1 11 DBREF 8R7U D 1 11 PDB 8R7U 8R7U 1 11 SEQADV 8R7U GLY B -1 UNP A0A7J6KAD EXPRESSION TAG SEQADV 8R7U HIS B 0 UNP A0A7J6KAD EXPRESSION TAG SEQADV 8R7U GLY A -1 UNP A0A7J6KAD EXPRESSION TAG SEQADV 8R7U HIS A 0 UNP A0A7J6KAD EXPRESSION TAG SEQRES 1 B 213 GLY HIS MET ALA PRO ALA PRO PRO ALA ASN SER GLY GLU SEQRES 2 B 213 SER SER LEU LEU SER GLU SER GLU LEU PRO ALA GLY ILE SEQRES 3 B 213 SER TYR ALA GLU ALA MET GLU GLY GLY SER ARG PRO LEU SEQRES 4 B 213 LEU HIS PRO ASP ASN PRO VAL VAL PHE PHE ASP ILE SER SEQRES 5 B 213 ILE GLY SER HIS GLU ALA GLY ARG ILE LYS ILE GLU LEU SEQRES 6 B 213 PHE LYS ASN LEU ALA PRO LYS SER ALA GLU ASN PHE ARG SEQRES 7 B 213 GLN PHE CYS THR GLY GLU PHE ARG GLN ASN GLN VAL PRO SEQRES 8 B 213 ILE GLY TYR LYS GLY ALA THR PHE HIS ARG ILE ILE LYS SEQRES 9 B 213 ASN PHE MET ILE GLN GLY GLY ASP PHE VAL LYS GLY ASP SEQRES 10 B 213 GLY THR GLY ARG LEU SER ILE TYR GLY SER SER PHE PRO SEQRES 11 B 213 ASP GLU ALA PHE VAL LEU PRO HIS PHE ARG SER GLY LEU SEQRES 12 B 213 LEU SER LEU ALA ASN SER GLY PRO ASP THR ASN GLY CYS SEQRES 13 B 213 GLN PHE PHE ILE THR CYS ALA LYS CYS ASP TRP LEU ASN SEQRES 14 B 213 ARG LYS HIS VAL VAL PHE GLY GLN VAL LEU GLY LYS GLU SEQRES 15 B 213 SER MET GLN VAL VAL ARG LYS ILE GLU HIS VAL THR VAL SEQRES 16 B 213 ASP GLY GLY ASN ARG PRO ARG ILE PRO VAL THR VAL THR SEQRES 17 B 213 GLN CYS GLY GLU LEU SEQRES 1 A 213 GLY HIS MET ALA PRO ALA PRO PRO ALA ASN SER GLY GLU SEQRES 2 A 213 SER SER LEU LEU SER GLU SER GLU LEU PRO ALA GLY ILE SEQRES 3 A 213 SER TYR ALA GLU ALA MET GLU GLY GLY SER ARG PRO LEU SEQRES 4 A 213 LEU HIS PRO ASP ASN PRO VAL VAL PHE PHE ASP ILE SER SEQRES 5 A 213 ILE GLY SER HIS GLU ALA GLY ARG ILE LYS ILE GLU LEU SEQRES 6 A 213 PHE LYS ASN LEU ALA PRO LYS SER ALA GLU ASN PHE ARG SEQRES 7 A 213 GLN PHE CYS THR GLY GLU PHE ARG GLN ASN GLN VAL PRO SEQRES 8 A 213 ILE GLY TYR LYS GLY ALA THR PHE HIS ARG ILE ILE LYS SEQRES 9 A 213 ASN PHE MET ILE GLN GLY GLY ASP PHE VAL LYS GLY ASP SEQRES 10 A 213 GLY THR GLY ARG LEU SER ILE TYR GLY SER SER PHE PRO SEQRES 11 A 213 ASP GLU ALA PHE VAL LEU PRO HIS PHE ARG SER GLY LEU SEQRES 12 A 213 LEU SER LEU ALA ASN SER GLY PRO ASP THR ASN GLY CYS SEQRES 13 A 213 GLN PHE PHE ILE THR CYS ALA LYS CYS ASP TRP LEU ASN SEQRES 14 A 213 ARG LYS HIS VAL VAL PHE GLY GLN VAL LEU GLY LYS GLU SEQRES 15 A 213 SER MET GLN VAL VAL ARG LYS ILE GLU HIS VAL THR VAL SEQRES 16 A 213 ASP GLY GLY ASN ARG PRO ARG ILE PRO VAL THR VAL THR SEQRES 17 A 213 GLN CYS GLY GLU LEU SEQRES 1 C 11 DAL MLE MLE MVA TMD ABA SAR MLE VAL MLE ALA SEQRES 1 D 11 DAL MLE MLE MVA TMD ABA SAR MLE VAL MLE ALA HET DAL C 1 5 HET MLE C 2 9 HET MLE C 3 9 HET MVA C 4 8 HET TMD C 5 13 HET ABA C 6 6 HET SAR C 7 5 HET MLE C 8 9 HET MLE C 10 9 HET DAL D 1 5 HET MLE D 2 9 HET MLE D 3 9 HET MVA D 4 8 HET TMD D 5 13 HET ABA D 6 6 HET SAR D 7 5 HET MLE D 8 9 HET MLE D 10 9 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM TMD (6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N-DIMETHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE FORMUL 3 DAL 2(C3 H7 N O2) FORMUL 3 MLE 8(C7 H15 N O2) FORMUL 3 MVA 2(C6 H13 N O2) FORMUL 3 TMD 2(C10 H21 N O3) FORMUL 3 ABA 2(C4 H9 N O2) FORMUL 3 SAR 2(C3 H7 N O2) FORMUL 5 HOH *448(H2 O) HELIX 1 AA1 SER B 25 GLU B 31 1 7 HELIX 2 AA2 ALA B 68 GLY B 81 1 14 HELIX 3 AA3 CYS B 163 ASN B 167 5 5 HELIX 4 AA4 GLY B 178 HIS B 190 1 13 HELIX 5 AA5 SER A 25 GLU A 31 1 7 HELIX 6 AA6 ALA A 68 GLY A 81 1 14 HELIX 7 AA7 CYS A 163 ASN A 167 5 5 HELIX 8 AA8 GLY A 178 HIS A 190 1 13 SHEET 1 AA1 8 PHE B 97 ILE B 101 0 SHEET 2 AA1 8 MET B 105 GLY B 108 -1 O GLN B 107 N ARG B 99 SHEET 3 AA1 8 PHE B 156 THR B 159 -1 O ILE B 158 N ILE B 106 SHEET 4 AA1 8 LEU B 141 LEU B 144 -1 N LEU B 141 O THR B 159 SHEET 5 AA1 8 VAL B 172 LEU B 177 -1 O GLY B 174 N LEU B 142 SHEET 6 AA1 8 HIS B 54 LEU B 63 -1 N GLU B 62 O GLN B 175 SHEET 7 AA1 8 VAL B 44 ILE B 51 -1 N ILE B 49 O ALA B 56 SHEET 8 AA1 8 VAL B 203 GLU B 210 -1 O GLN B 207 N ASP B 48 SHEET 1 AA2 2 ARG B 84 GLN B 85 0 SHEET 2 AA2 2 VAL B 88 PRO B 89 -1 O VAL B 88 N GLN B 85 SHEET 1 AA3 8 PHE A 97 ILE A 101 0 SHEET 2 AA3 8 MET A 105 GLY A 108 -1 O GLN A 107 N ARG A 99 SHEET 3 AA3 8 PHE A 156 THR A 159 -1 O ILE A 158 N ILE A 106 SHEET 4 AA3 8 LEU A 141 LEU A 144 -1 N LEU A 141 O THR A 159 SHEET 5 AA3 8 VAL A 172 LEU A 177 -1 O GLY A 174 N LEU A 142 SHEET 6 AA3 8 HIS A 54 LEU A 63 -1 N GLU A 62 O GLN A 175 SHEET 7 AA3 8 VAL A 44 ILE A 51 -1 N VAL A 45 O ILE A 61 SHEET 8 AA3 8 VAL A 203 GLU A 210 -1 O GLN A 207 N ASP A 48 SHEET 1 AA4 2 ARG A 84 GLN A 85 0 SHEET 2 AA4 2 VAL A 88 PRO A 89 -1 O VAL A 88 N GLN A 85 LINK C DAL C 1 N MLE C 2 1555 1555 1.49 LINK N DAL C 1 C ALA C 11 1555 1555 1.50 LINK C MLE C 2 N MLE C 3 1555 1555 1.48 LINK C MLE C 3 N MVA C 4 1555 1555 1.48 LINK C MVA C 4 N TMD C 5 1555 1555 1.51 LINK C TMD C 5 N ABA C 6 1555 1555 1.52 LINK C ABA C 6 N SAR C 7 1555 1555 1.54 LINK C SAR C 7 N MLE C 8 1555 1555 1.54 LINK C MLE C 8 N VAL C 9 1555 1555 1.52 LINK C VAL C 9 N MLE C 10 1555 1555 1.50 LINK C MLE C 10 N ALA C 11 1555 1555 1.49 LINK C DAL D 1 N MLE D 2 1555 1555 1.52 LINK N DAL D 1 C ALA D 11 1555 1555 1.53 LINK C MLE D 2 N MLE D 3 1555 1555 1.53 LINK C MLE D 3 N MVA D 4 1555 1555 1.52 LINK C MVA D 4 N TMD D 5 1555 1555 1.52 LINK C TMD D 5 N ABA D 6 1555 1555 1.53 LINK C ABA D 6 N SAR D 7 1555 1555 1.53 LINK C SAR D 7 N MLE D 8 1555 1555 1.52 LINK C MLE D 8 N VAL D 9 1555 1555 1.54 LINK C VAL D 9 N MLE D 10 1555 1555 1.53 LINK C MLE D 10 N ALA D 11 1555 1555 1.51 CRYST1 38.346 118.109 47.460 90.00 103.67 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026078 0.000000 0.006343 0.00000 SCALE2 0.000000 0.008467 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021685 0.00000